(Q40274567)

19 September 2017

Dengue vaccine development: a 75% solution? (English)

1 reference

19 September 2017

0 references

Scott B Halstead

1

1 reference

PubMed ID

22975339

19 September 2017

language of work or name

English

0 references

publication date

11 September 2012

1 reference

19 September 2017

1 reference

19 September 2017

380

1 reference

19 September 2017

1535-1536

1 reference

19 September 2017

9853

1 reference

Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961510-4

7 January 2021

Refining the global spatial limits of dengue virus transmission by evidence-based consensus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961510-4

7 January 2021

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961510-4

7 January 2021

Japanese encephalitis: new options for active immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961510-4

7 January 2021

Immune response to dengue virus and prospects for a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961510-4

7 January 2021

Live-attenuated, tetravalent dengue vaccine in children, adolescents and adults in a dengue endemic country: randomized controlled phase I trial in the Philippines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961510-4

7 January 2021

Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961510-4

7 January 2021

Evaluation of interferences between dengue vaccine serotypes in a monkey model.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961510-4

7 January 2021

The human antibody response to dengue virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961510-4

7 January 2021

Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961510-4

7 January 2021

The impact of the demographic transition on dengue in Thailand: insights from a statistical analysis and mathematical modeling

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2961510-4

7 January 2021

10.1016/S0140-6736(12)61510-4

Identifiers

DOI

1 reference

19 September 2017

1 reference

PubMed ID

22975339